2018
DOI: 10.1071/ma18039
|View full text |Cite
|
Sign up to set email alerts
|

Microbiotechnologies for steroid production

Abstract: Structural modification of steroids by microorganisms, known since the 1950s, is nowadays a base for industrial production of many steroid hormones and their high-value precursors. Phytosterols, renewable biomaterials of plant origin, are recognised now as most attractive, low-cost and available raw materials for the pharmaceutical industry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Microbial transformation can replace acid hydrolysis to produce diosgenin with high efficiency and environmental protection (Chen et al, 2018). At the same time, microbial biotechnologies play a significant role in the pharmaceutical steroid industry (Donova, 2018). The pharmacological effects of steroidal saponins are closely related to structural characteristics such as sugar chains, glycosyl types, and substituents (Wang et al, 2010;Prawat et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Microbial transformation can replace acid hydrolysis to produce diosgenin with high efficiency and environmental protection (Chen et al, 2018). At the same time, microbial biotechnologies play a significant role in the pharmaceutical steroid industry (Donova, 2018). The pharmacological effects of steroidal saponins are closely related to structural characteristics such as sugar chains, glycosyl types, and substituents (Wang et al, 2010;Prawat et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…However, at present, PS also emerge as cost-effective substrates for optimized bioconversion into steroid intermediates (known as synthons) by genetically engineered strains [ 17 , 342 ]. The concept of steroid biotransformation is far from being new (1950s) [ 343 ] but considering that steroid-based drugs are one of the highest marketed categories of pharmaceuticals [ 342 , 344 ], the possibility of bypassing classical steroid synthesis approaches or direct extraction from plant/animal sources makes this a growing area of industrial biotechnology, which is also reflected in several patented works ( Figure 11 ) [ 19 , 20 , 21 , 22 , 28 ]. In fact, large-scale industrial PS bioconversion to key androstane-type synthons has already been introduced in Germany, USA, China, India, among others [ 17 ].…”
Section: Applications Of Psmentioning
confidence: 99%
“…With preferential cheap raw materials from already discussed sources, cholesterol, sitosterol, stigmasterol, campesterol, and brassicasterol can be considered the main substrates. Products of PS biotransformation can include C-19 synthons such as androstenedione (AD) and 1,4-androstadiene-3,17-dione (ADD), and C-22 derivatives such as 20-hydroxymethylpregna-1,4-dien-3-one (20-HMP), all of which are a staple in chemical synthesis of several key steroids, including sex hormones, anabolic steroids, and adrenocortical hormones [ 17 , 343 ]. In general terms, the main process comprises a selective sidechain cleavage of the sterol molecule and the transformation of the 3-β-ol-5,6-dehydro structure of the steroid nucleus to a 3-keto-4-ene via catabolic enzymatic systems, such as in sitosterol biotransformation to AD by Mycobacterium sp.…”
Section: Applications Of Psmentioning
confidence: 99%
See 1 more Smart Citation
“…As one of the well-known androgen steroids, androst-1,4-diene-3,17-dione (ADD) was extensively used as an important precursor for the synthesis of steroid hormone medicines in the pharmaceutical industry [1]. Traditionally, ADD was obtained from natural steroids such as sapogenin and diosgenin using multistep chemical degradation and modification methods.…”
Section: Introductionmentioning
confidence: 99%